Ukraine has issued multiple amendments and draft orders to modernize its clinical study procedures, state clinical trial registry, and unregistered medicinal product importation protocols for medicinal products.
Ukraine’s Ministry of Health has proposed formal rules for running a national registry of clinical trials of medicines. Companies and the public can send comments until 5 November 2026.
The ministry published a draft order on how the State Register of Clinical Studies (Trials) of Medicinal Products will be kept1. The draft also changes Ukraine’s new rulebook for running clinical trials, which takes effect on 1 January 20272. Comments are open for 30 days, from 7 October to 5 November 20261.
| At a glance | Details |
|---|---|
| What was published | Draft order on keeping the State Register of Clinical Studies (Trials) of Medicinal Products |
| Published on | Comment period opened 7 October 2026 |
| Who can comment / Who must comply | Anyone may comment; the draft regulates medicine manufacturers |
| Feedback deadline / Effective date | Comments due 5 November 2026 |
| Final rules / Next milestone | Ministry review, then the new clinical trial rulebook takes effect 1 January 2027 |
What is the clinical trial registry, and why does it matter?
A clinical trial tests a medicine on people to check that it is safe and works. Ukraine’s medicines law calls for a state registry of these trials, and for rules on how it operates. The draft order is meant to put that part of the law of 28 July 2022, No. 2469-IX, into practice1.
The registry rules will sit beside the new clinical trial rulebook. That rulebook was approved by ministry order No. 184 of 16 February 20261. It was registered with the Ministry of Justice on 15 April 20262.
What the draft order contains
The draft approves two documents1:
- A procedure for keeping the registry, setting out how it works.
- Changes to the clinical trial rulebook approved by order No. 184.
The ministry’s notice gives the draft’s purpose but not the detailed registry fields. Those are in the draft text and supporting papers posted with the notice. These include an analysis of the rule’s business impact, an explanatory note and a table comparing old and new wording1.
Who is affected
The ministry says the rules will affect large, medium and small businesses1. The reason given is that the draft regulates the work of medicine manufacturers1.
In practice, trial sponsors also work under the rulebook the draft amends. Order No. 184 sets duties for sponsors and investigators, the doctors who run a trial at a hospital or clinic2. Those duties include reporting side effects, filing progress reports and notifying the end of a study2.
| Area in the rulebook | What it covers |
|---|---|
| Protection of trial participants | Information for volunteers, and special rules for children, some adults and pregnant women2 |
| Investigators and sites | Requirements for doctors and the hospitals that host trials2 |
| Changes during a trial | Approval of substantial changes to a study plan2 |
| Safety reporting | Reports of adverse events by investigators and sponsors2 |
| End of a trial | Notice of completion and a summary of the results2 |
How trials are approved today
Until the new rulebook starts, trials still run under an older procedure from 2009. That procedure was set by ministry order No. 690 of 23 Sept. 20093. The ministry keeps issuing approvals under it.
On 16 October 2026 the ministry issued order No. 15973. It permitted new clinical trials listed in two annexes. It also approved substantial changes to existing trial plans listed in 18 further annexes3. The decision relied on conclusions from the State Expert Centre, the ministry’s medicines review body, sent on 8 October 20263.
How to send comments
Comments go to the Ministry of Health in Kyiv, on paper or by email1. They must be set out as a table comparing the current and proposed wording1. The draft was prepared by the ministry’s department for digital change and innovation in health care1.
| Key date | What happens |
|---|---|
| 15 April 2026 | Clinical trial rulebook (order No. 184) registered with the Ministry of Justice2 |
| 7 October 2026 | Comment period on the registry draft opens1 |
| 16 October 2026 | Ministry approves new trials and trial changes under the old procedure3 |
| 5 November 2026 | Comment period closes1 |
| 1 January 2027 | New clinical trial rulebook takes effect2 |
Key terms in plain words
| Term | Meaning |
|---|---|
| Clinical trial | A study that tests a medicine on people to check safety and effect |
| Registry | An official public list of clinical trials kept by the state |
| Sponsor | The company or body that starts, funds and manages a trial |
| Investigator | The doctor responsible for running the trial at a site |
| Substantial change | A significant change to a trial plan that needs approval |
| State Expert Centre | The ministry’s body that reviews medicines and trial files |
The comment period on the registry draft closes on 5 November 20261.
Sources
- ↩ ПОВІДОМЛЕННЯ про оприлюднення регуляторного акта проєкту наказу Міністерства охорони здоров’я України «Деякі питання ведення Державного реєстру клінічних досліджень (випробувань) лікарських засобів» https://moz.gov.ua/uk/povidomlennya-pro-oprilyudnennya-regulyatornogo-akta-proyektu-nakazu-ministerstva-ohoroni-zdorov-ya-ukrayini-deyaki-pitannya-vedennya-derzhavnogo-reyestru-klinichnih-doslidzhen-viprobuvan-likarskih-zasobiv
- ↩ Деякі питання порядку проведення… | від 16.02.2026 № 184 https://zakon.rada.gov.ua/go/z0516-26
- ↩ Наказ https://moz.gov.ua/uk/decrees/nakaz-moz-ukrayini-vid-16-10-2026-1597-pro-provedennya-klinichnih-viprobuvan-likarskih-zasobiv-ta-zatverdzhennya-suttyevih-popravok